CardioID Technologies
CardioID Technologies is a Portuguese deep-tech spinoff from Instituto Superior Técnico that builds AI-driven ECG biometric solutions for automotive driver monitoring (CardioWheel), remote cardiac rehabilitation (ConnectedHeart), and clinical biosensing, selling to automotive OEMs and healthcare providers via licensing, subscription, and hardware channels.
- Company typePrivate
- Founded2014
- HeadquartersMatosinhos, Portugal
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What CardioID Technologies does
CardioID Technologies Lda is a Portuguese deep-technology company founded in 2014 as a spin-off from Instituto Superior Técnico (University of Lisbon). The company develops proprietary ECG biometric technology that applies artificial intelligence and machine learning to multivariate analysis of electrocardiographic signals, delivering biometric identification, drowsiness and fatigue detection, and cardiac health monitoring applications. Its portfolio centers on the Heartmetrics platform and three core product lines: CardioWheel (an in-vehicle driver monitoring system that acquires ECG signals seamlessly through the steering wheel for drowsiness alerts, health monitoring, and biometric identity verification), ConnectedHeart (a digital cardiac rehabilitation platform combining in-person sessions with remote non-intrusive monitoring), and CardioLeather (conductive leather with embedded biosensors for vehicle interior surfaces). Supporting innovations include the T-PRISM multimodal clinical monitoring platform and ECG-based biometric identity recognition systems for security applications.
The company serves two primary verticals — automotive OEMs and tier-1 suppliers (addressing driver safety and in-cabin health sensing) and healthcare providers running cardiac rehabilitation programs — with a secondary industrial/workplace safety use case. Revenue mechanics span three streams: licensing of proprietary ECG biometric IP, subscription revenue from the ConnectedHeart platform, and hardware sales of integrated automotive monitoring systems. Distribution is enterprise-direct with custom quoting, supplemented by technology integration partnerships (e.g., Express Glass in ADAS) and active participation in EU-funded research consortia (i-DREAMS, VALU3S, T-PRISM) and trade events (MEDICA, Web Summit, Health Cluster Portugal).
The company operates with 1–10 employees across offices in Óbidos (HQ at the Óbidos Technology Park), Lisbon (R&D at ISEL), and São Paulo, Brazil. It is privately held and founder-led, with no institutional investment disclosed. CardioID's competitive position rests on a granted patent on ECG biometric methodology, 70+ research publications, recognition including Ford MakeItDriveable (2019) and Fujitsu Co-Creation World Tour (2018) wins, and the 2025 SIFIDE Scientific and Technological Suitability Seal from Portugal's National Innovation Agency.
CardioID Technologies firmographics
Firmographics- Name
- CardioID Technologies
- Legal name
- CARDIOID TECHNOLOGIES Lda
- Website
- https://cardio-id.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- CardioID Technologies is a Portuguese deep-tech spinoff from Instituto Superior Técnico that builds AI-driven ECG biometric solutions for automotive driver monitoring (CardioWheel), remote cardiac rehabilitation (ConnectedHeart), and clinical biosensing, selling to automotive OEMs and healthcare providers via licensing, subscription, and hardware channels.
- Ownership category
- akta.pro rank
CardioID Technologies industry classification
Industry- Product category
- Biometric Cardiac Monitoring Technology
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)
- akta.pro secondary industries
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Cardiology Telemedicine Platforms (HLALAGAB), ECG/EKG & Heart Rhythm Monitors (Consumer) (CRACAQAC)
Keywords
Where CardioID Technologies is headquartered
LocationHeadquarters
- HQ city
- Matosinhos
- HQ country
- Portugal
- HQ region
- Europe
Offices3 records
Markets served
CardioID Technologies business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- ECG Biometric Technology Licensing: Licensing of proprietary ECG biometric technology for integration into automotive and healthcare products.
- Healthcare Solutions: ConnectedHeart cardiac rehabilitation platform providing remote patient monitoring services.
- Automotive Biometric Systems: CardioWheel and related driver monitoring systems sold to automotive manufacturers.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
CardioID Technologies product offering
Product offeringCore offering
CardioID develops ECG-based biometric and cardiac monitoring technology licensed to automotive OEMs (driver drowsiness/fatigue detection, identity verification, health alerts via steering-wheel sensors) and sold/licensed to healthcare providers (digital cardiac rehabilitation platform, remote patient monitoring). The company designs the full production cycle — electronic circuits, embedded software, signal-processing algorithms, and finished integrated products — leveraging patented multivariate ECG analysis and AI/ML.
Product overview
CardioID Technologies operates as a multi-product company built around its Heartmetrics technology platform, which extracts knowledge from multivariate analysis of electrocardiographic (ECG) signals. The portfolio centers on two core product lines: CardioWheel (automotive driver monitoring with ECG biometrics, drowsiness detection, and health alerts) and ConnectedHeart (digital cardiac rehabilitation platform combining in-person sessions with remote monitoring). Supporting innovations include CardioLeather (conductive leather with embedded biosensors for vehicle interiors), the T-PRISM multimodal clinical monitoring platform for sanitary applications, and ECG-based biometric identity recognition systems. The company produces devices ranging from steering wheel-integrated sensors to mobile apps and clinical monitoring platforms, all leveraging its core expertise in ECG signal processing, pattern recognition, and machine learning.
Differentiator
Problem solved
Functional benefit
Brands
- CardioWheel: Advanced driver-assistance system for automotive sector that provides seamless ECG signal acquisition and advanced pattern recognition for drowsiness alerts, driver health monitoring, and driver identity verification
- ConnectedHeart
- CardioLeather
- Heartmetrics
Products and services
- CardioWheel Advanced driver-assistance system integrated into vehicle steering wheels, using seamless ECG signal acquisition and pattern recognition to deliver drowsiness alerts, continuous driver health monitoring, and biometric identity verification. Designed for automotive OEMs and Tier-1 suppliers seeking in-cabin driver-state sensing.
- ConnectedHeart Digital platform integrating physiological and behavioral data to support hybrid and remote cardiac rehabilitation programs. Combines in-person sessions with remote non-intrusive cardiac monitoring, providing clinicians with real-time patient data and patients with a mobile app for guidance and motivation. Targeted at hospitals, cardiac rehabilitation centers, and healthcare providers.
- CardioLeather Conductive leather with embedded electronics for physiological signal acquisition on vehicle surfaces such as steering wheels, enabling continuous and non-intrusive occupant identity verification, health monitoring, and wellbeing assessment. Developed as a Portugal 2020/COMPETE co-funded R&D project led by CardioID with Couro Azul, CTIC, IST, and University of Aveiro.
- T-PRISM Biosensor System Multimodal platform for invisible clinical monitoring in sanitary applications, collecting clinical data from urinalysis (14 biomarkers), ECG, PPG, bioimpedance, temperature, weight, and fecal analysis. CardioID is responsible for the sensorization task within the T-PRISM consortium.
- Heartmetrics Technology Platform Overarching technology platform that extracts knowledge from multivariate analysis of electrocardiographic (ECG) signals to develop human factors-related devices and applications across automotive, healthcare, biometrics and cybersecurity, and human factors engineering domains.
- ECG Biometric Identity Recognition Technology using the unique characteristics of each individual's ECG for person identification, enabling systems with more secure procedures and personalized information across automotive and security applications.
Quantifiable outcome
- Cardiac rehabilitation programs with robust monitoring can reduce mortality by up to 30%
Companies that use CardioID Technologies
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
CardioID Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
CardioID Technologies partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- AblutecoreLeading the T-PRISM (Toilet Platform for Real-time Integrated Sensing and Monitoring) project consortium. CardioID contributes expertise in biosensors and data analysis, responsible for sensorization tasks in this multimodal health monitoring platform.
- DestinyCloudminorPartner in T-PRISM consortium for invisible clinical monitoring platform.
- CCG (Centro de Computação Gráfica)minorResearch partner in T-PRISM consortium.
- PIEPminorInnovation partner in T-PRISM consortium.
- CeNTIminorNanotechnology research partner in T-PRISM consortium.
- INESC MNminorResearch partner in T-PRISM consortium focused on micro and nanotechnology.
- Express GlasscorePartnership established within the Advanced Driver-Assistance Systems (ADAS) segment for integrating CardioID's biometric technology.
- i-DREAMS ConsortiumcoreH2020 project consortium of 13 partners from 8 European countries focused on intelligent driver assessment and monitoring system. CardioID provides driver psychophysiological monitoring devices.
- Health Cluster PortugalcoreCardioID is a member of Health Cluster Portugal, participating in health innovation conferences and initiatives to advance digital health in Portugal.
- Instituto Superior TécnicocoreSpin-off originating from Instituto Superior Técnico (University of Lisbon). Ongoing collaborative research and development partnerships.
- VALU3S ConsortiumcoreEuropean project for Verification and Validation of automated systems' safety and security. CardioID applies V&V methods to ensure safety and reliability of CardioWheel.
- CardioLeather ConsortiumcoreCo-funded by Portugal 2020/COMPETE program. CardioID leads consortium with Couro Azul, CTIC, Instituto Superior Técnico, and Universidade de Aveiro to develop conductive leather with embedded physiological signal acquisition electronics.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
CardioID Technologies competitors and assessment
Company assessmentDirect peers
- B-Secur: B-Secur applies ECG-based biometric authentication for automotive, security, and health use cases. It is a direct peer to CardioID's ECG biometric identity recognition sub-product.
- Smart Eye: Smart Eye provides AI-based driver monitoring systems for automotive OEMs, focused on eye tracking and cabin sensing. It competes with CardioID's CardioWheel for the same driver drowsiness and attention monitoring mandate triggered by EU safety regulations.
- Seeing Machines: Seeing Machines develops DMS and occupant monitoring technology for automotive and aviation. It directly competes with CardioID's CardioWheel for OEM design wins in driver attention and drowsiness detection.
- BioIntellisense: BioIntellisense offers continuous multi-parameter wearable RPM for clinical and remote care. It is comparable to ConnectedHeart on continuous cardiac biosensing and subscription RPM models.
- iRhythm Technologies: iRhythm's Zio patch is a wearable ECG monitor for cardiac arrhythmia detection. It is comparable to CardioID on the ECG cardiac-monitoring core and on the connected cardiac-care business model.
Broad incumbents
- Bosch: Bosch is a major automotive Tier-1 supplier with broad driver-assistance and cabin-monitoring portfolios. It competes with CardioID on automotive OEM integrations at a much larger scale and broader sensor modality.
- Preventice Solutions (Boston Scientific): Preventice (now part of Boston Scientific) provides ambulatory cardiac monitoring and remote cardiac diagnostics. It competes with ConnectedHeart in remote cardiac monitoring and arrhythmia detection at significantly larger scale.
- Continental: Continental supplies integrated DMS and ADAS solutions to global OEMs. It is an incumbent alternative to CardioID's CardioWheel with established OEM relationships and large R&D resources.
Emerging players
- Neteera: Neteera develops contactless biosensing for vital signs including heart activity. It overlaps with CardioID on non-intrusive cardiac monitoring and biometric sensing for health and automotive contexts.
- Empatica: Empatica builds medical-grade wearable biosensors for continuous health monitoring, including cardiac metrics. It overlaps with CardioID's ConnectedHeart on wearable-based cardiac RPM.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
CardioID Technologies social profiles
Digital presenceCardioID Technologies compliance and trust
Trust signalCompliance2 records
CardioID Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
CardioID Technologies leadership team
Management profileNumber of profiles
Profiles3 records
CardioID Technologies funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CardioID Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CardioID Technologies
What does CardioID Technologies do?
CardioID develops ECG-based biometric and cardiac monitoring technology licensed to automotive OEMs (driver drowsiness/fatigue detection, identity verification, health alerts via steering-wheel sensors) and sold/licensed to healthcare providers (digital cardiac rehabilitation platform, remote patient monitoring). The company designs the full production cycle — electronic circuits, embedded software, signal-processing algorithms, and finished integrated products — leveraging patented multivariate ECG analysis and AI/ML.
Is CardioID Technologies a public or private company?
CardioID Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CardioID Technologies founded?
CardioID Technologies was founded in 2014. It employs 1 to 10 people.
Where is CardioID Technologies based?
CardioID Technologies is headquartered in Matosinhos, Portugal, in the Europe region.
How does CardioID Technologies make money?
Three revenue lines are on record. ECG Biometric Technology Licensing is the primary driver. The others are healthcare Solutions and automotive Biometric Systems.
Who are CardioID Technologies's main competitors?
Direct peers on record are B-Secur, Smart Eye, Seeing Machines, BioIntellisense and iRhythm Technologies. Broad incumbents are Bosch, Preventice Solutions (Boston Scientific) and Continental. Emerging players are Neteera and Empatica.
Does CardioID Technologies have an API?
No public API is recorded for CardioID Technologies.
What industry is CardioID Technologies in?
CardioID Technologies's product category is Biometric Cardiac Monitoring Technology. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 334510 and its SIC code is 3845.